APO Research
Talk to an analyst

APO RESEARCH · REPORT

HIV and AIDS Diagnostics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global HIV and AIDS Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 March 2026193 pages

Choose your research edition.

Industry ResearchHIV and AIDS Diagnostics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal HIV and AIDS Diagnostics Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal HIV and AIDS Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HIV and AIDS Diagnostics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal HIV and AIDS Diagnostics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global HIV and AIDS Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for HIV and AIDS Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for HIV and AIDS Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HIV and AIDS Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for HIV and AIDS Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HIV and AIDS Diagnostics include Siemens Healthineers, Bio-Rad, Abbott Laboratories, OraSure TechnologieS, F. Hoffmann-La Roche, Hologic, Abbott, Chembio Diagnostic Systems and BD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global HIV and AIDS Diagnostics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of HIV and AIDS Diagnostics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents HIV and AIDS Diagnostics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the HIV and AIDS Diagnostics market size, projected growth trends, production technologies, key applications, and end-use industries.

HIV and AIDS Diagnostics Segment by Company

Siemens Healthineers

Bio-Rad

Abbott Laboratories

OraSure TechnologieS

F. Hoffmann-La Roche

Hologic

Abbott

Chembio Diagnostic Systems

BD

Danaher Corporation

HIV and AIDS Diagnostics Segment by Type

Reagent Test Kit

Instrument

Others

HIV and AIDS Diagnostics Segment by Application

Hospitals

Private Diagnostic Laboratories

Academic and Research Institutes

HIV and AIDS Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV and AIDS Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HIV and AIDS Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV and AIDS Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of HIV and AIDS Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global HIV and AIDS Diagnostics industry.

Chapter 3: Detailed analysis of HIV and AIDS Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV and AIDS Diagnosticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HIV and AIDS Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Reagent Test Kit Table 3. Key Players of Instrument Table 4. Key Players of Others Table 4. Global HIV and AIDS Diagnostics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of Private Diagnostic Laboratories Table 7. Key Players of Academic and Research Institutes Table 8. Global HIV and AIDS Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global HIV and AIDS Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 10. Global HIV and AIDS Diagnostics Market Share by Region (2021-2026) Table 11. Global HIV and AIDS Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 12. Global HIV and AIDS Diagnostics Market Share by Region (2027-2032) Table 13. HIV and AIDS Diagnostics Industry Trends Table 14. HIV and AIDS Diagnostics Industry Drivers Table 15. HIV and AIDS Diagnostics Industry Opportunities and Challenges Table 16. HIV and AIDS Diagnostics Industry Restraints Table 17. Global HIV and AIDS Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 18. Global HIV and AIDS Diagnostics Revenue Market Share by Company (2021-2026) Table 19. Global HIV and AIDS Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global HIV and AIDS Diagnostics Key Company Head Office and Area Served Table 21. Global HIV and AIDS Diagnostics Company, Product Type & Application Table 22. Global HIV and AIDS Diagnostics Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global HIV and AIDS Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global HIV and AIDS Diagnostics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global HIV and AIDS Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 27. Global HIV and AIDS Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 28. Global HIV and AIDS Diagnostics Revenue Market Share by Type (2021-2026) Table 29. Global HIV and AIDS Diagnostics Revenue Market Share by Type (2027-2032) Table 30. Global HIV and AIDS Diagnostics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global HIV and AIDS Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 32. Global HIV and AIDS Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 33. Global HIV and AIDS Diagnostics Revenue Market Share by Application (2021-2026) Table 34. Global HIV and AIDS Diagnostics Revenue Market Share by Application (2027-2032) Table 35. Siemens Healthineers Company Information Table 36. Siemens Healthineers Business Overview Table 37. Siemens Healthineers HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Siemens Healthineers HIV and AIDS Diagnostics Product Portfolio Table 39. Siemens Healthineers Recent Development Table 40. Bio-Rad Company Information Table 41. Bio-Rad Business Overview Table 42. Bio-Rad HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Bio-Rad HIV and AIDS Diagnostics Product Portfolio Table 44. Bio-Rad Recent Development Table 45. Abbott Laboratories Company Information Table 46. Abbott Laboratories Business Overview Table 47. Abbott Laboratories HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Abbott Laboratories HIV and AIDS Diagnostics Product Portfolio Table 49. Abbott Laboratories Recent Development Table 50. OraSure TechnologieS Company Information Table 51. OraSure TechnologieS Business Overview Table 52. OraSure TechnologieS HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. OraSure TechnologieS HIV and AIDS Diagnostics Product Portfolio Table 54. OraSure TechnologieS Recent Development Table 55. F. Hoffmann-La Roche Company Information Table 56. F. Hoffmann-La Roche Business Overview Table 57. F. Hoffmann-La Roche HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. F. Hoffmann-La Roche HIV and AIDS Diagnostics Product Portfolio Table 59. F. Hoffmann-La Roche Recent Development Table 60. Hologic Company Information Table 61. Hologic Business Overview Table 62. Hologic HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Hologic HIV and AIDS Diagnostics Product Portfolio Table 64. Hologic Recent Development Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Abbott HIV and AIDS Diagnostics Product Portfolio Table 69. Abbott Recent Development Table 70. Chembio Diagnostic Systems Company Information Table 71. Chembio Diagnostic Systems Business Overview Table 72. Chembio Diagnostic Systems HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Chembio Diagnostic Systems HIV and AIDS Diagnostics Product Portfolio Table 74. Chembio Diagnostic Systems Recent Development Table 75. BD Company Information Table 76. BD Business Overview Table 77. BD HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. BD HIV and AIDS Diagnostics Product Portfolio Table 79. BD Recent Development Table 80. Danaher Corporation Company Information Table 81. Danaher Corporation Business Overview Table 82. Danaher Corporation HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Danaher Corporation HIV and AIDS Diagnostics Product Portfolio Table 84. Danaher Corporation Recent Development Table 85. North America HIV and AIDS Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 86. North America HIV and AIDS Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 87. North America HIV and AIDS Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 88. North America HIV and AIDS Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 89. North America HIV and AIDS Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America HIV and AIDS Diagnostics Market Size by Country (2021-2026) Table 91. North America HIV and AIDS Diagnostics Market Size by Country (2027-2032) Table 92. Europe HIV and AIDS Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe HIV and AIDS Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe HIV and AIDS Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe HIV and AIDS Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe HIV and AIDS Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe HIV and AIDS Diagnostics Market Size by Country (2021-2026) Table 98. Europe HIV and AIDS Diagnostics Market Size by Country (2027-2032) Table 99. China HIV and AIDS Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 100. China HIV and AIDS Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 101. China HIV and AIDS Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 102. China HIV and AIDS Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia HIV and AIDS Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia HIV and AIDS Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia HIV and AIDS Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia HIV and AIDS Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia HIV and AIDS Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia HIV and AIDS Diagnostics Market Size by Country (2021-2026) Table 109. Asia HIV and AIDS Diagnostics Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. HIV and AIDS Diagnostics Product Image Figure 2. Global HIV and AIDS Diagnostics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global HIV and AIDS Diagnostics Market Share by Type: 2025 VS 2032 Figure 4. Reagent Test Kit Image Figure 5. Instrument Image Figure 6. Others Image Figure 7. Global HIV and AIDS Diagnostics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global HIV and AIDS Diagnostics Market Share by Application: 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Private Diagnostic Laboratories Image Figure 11. Academic and Research Institutes Image Figure 12. Global HIV and AIDS Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 14. Global HIV and AIDS Diagnostics Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global HIV and AIDS Diagnostics Market Share by Players in 2025 Figure 17. Global Top 5 and 10 HIV and AIDS Diagnostics Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global HIV and AIDS Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global HIV and AIDS Diagnostics Revenue Market Share by Type (2021-2032) Figure 21. Global HIV and AIDS Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global HIV and AIDS Diagnostics Revenue Market Share by Application (2021-2032) Figure 23. North America HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 24. North America HIV and AIDS Diagnostics Market Share by Type (2021-2032) Figure 25. North America HIV and AIDS Diagnostics Market Share by Application (2021-2032) Figure 26. North America HIV and AIDS Diagnostics Market Share by Country (2021-2032) Figure 27. United States HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 28. Canada HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 29. Mexico HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 30. Europe HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 31. Europe HIV and AIDS Diagnostics Market Share by Type (2021-2032) Figure 32. Europe HIV and AIDS Diagnostics Market Share by Application (2021-2032) Figure 33. Europe HIV and AIDS Diagnostics Market Share by Country (2021-2032) Figure 34. Germany HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 35. France HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 36. U.K. HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 37. Italy HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 38. Russia HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 40. China HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 41. China HIV and AIDS Diagnostics Market Share by Type (2021-2032) Figure 42. China HIV and AIDS Diagnostics Market Share by Application (2021-2032) Figure 43. Asia HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 44. Asia HIV and AIDS Diagnostics Market Share by Type (2021-2032) Figure 45. Asia HIV and AIDS Diagnostics Market Share by Application (2021-2032) Figure 46. Asia HIV and AIDS Diagnostics Market Share by Country (2021-2032) Figure 47. Japan HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 48. South Korea HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 51. India HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 52. Australia HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa HIV and AIDS Diagnostics Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa HIV and AIDS Diagnostics Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa HIV and AIDS Diagnostics Market Share by Country (2021-2032) Figure 57. Brazil HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 58. South Africa HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 60. Turkey HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 61. Argentina HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 62. UAE HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 63. Egypt HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 64. Chile HIV and AIDS Diagnostics Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Reagent Test Kit
  • Instrument
  • Others
Applications
  • Hospitals
  • Private Diagnostic Laboratories
  • Academic and Research Institutes
Companies covered
  • Siemens Healthineers
  • Bio-Rad
  • Abbott Laboratories
  • OraSure TechnologieS
  • F. Hoffmann-La Roche
  • Hologic
  • Abbott
  • Chembio Diagnostic Systems
  • BD
  • Danaher Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global HIV and AIDS Diagnostics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Reagent Test Kit
  5. 1.2.3 Instrument
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global HIV and AIDS Diagnostics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Private Diagnostic Laboratories
  11. 1.3.4 Academic and Research Institutes
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global HIV and AIDS Diagnostics Growth Trends by Region
  14. 1.5.1 Global HIV and AIDS Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 HIV and AIDS Diagnostics Market Size by Region (2021-2026)
  16. 1.5.3 HIV and AIDS Diagnostics Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global HIV and AIDS Diagnostics Market Dynamics
  1. 2.1 HIV and AIDS Diagnostics Industry Trends
  2. 2.2 HIV and AIDS Diagnostics Industry Drivers
  3. 2.3 HIV and AIDS Diagnostics Industry Opportunities and Challenges
  4. 2.4 HIV and AIDS Diagnostics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global HIV and AIDS Diagnostics Revenue by Company (2021-2026)
  2. 3.2 Global HIV and AIDS Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global HIV and AIDS Diagnostics Key Company Head office and Area Served
  4. 3.4 Global HIV and AIDS Diagnostics Company, Product Type & Application
  5. 3.5 Global HIV and AIDS Diagnostics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global HIV and AIDS Diagnostics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 HIV and AIDS Diagnostics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 HIV and AIDS Diagnostics Tier 1, Tier 2, and Tier 3
4 HIV and AIDS Diagnostics Market by Type
  1. 4.1 Global HIV and AIDS Diagnostics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global HIV and AIDS Diagnostics Market Size by Type (2021-2032)
  3. 4.3 Global HIV and AIDS Diagnostics Market Size Share by Type (2021-2032)
5 HIV and AIDS Diagnostics Market by Application
  1. 5.1 Global HIV and AIDS Diagnostics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global HIV and AIDS Diagnostics Market Size by Application (2021-2032)
  3. 5.3 Global HIV and AIDS Diagnostics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Siemens Healthineers
  2. 6.1.1 Siemens Healthineers Company Information
  3. 6.1.2 Siemens Healthineers Business Overview
  4. 6.1.3 Siemens Healthineers HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Siemens Healthineers HIV and AIDS Diagnostics Product Portfolio
  6. 6.1.5 Siemens Healthineers Recent Developments
  7. 6.2 Bio-Rad
  8. 6.2.1 Bio-Rad Company Information
  9. 6.2.2 Bio-Rad Business Overview
  10. 6.2.3 Bio-Rad HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bio-Rad HIV and AIDS Diagnostics Product Portfolio
  12. 6.2.5 Bio-Rad Recent Developments
  13. 6.3 Abbott Laboratories
  14. 6.3.1 Abbott Laboratories Company Information
  15. 6.3.2 Abbott Laboratories Business Overview
  16. 6.3.3 Abbott Laboratories HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Abbott Laboratories HIV and AIDS Diagnostics Product Portfolio
  18. 6.3.5 Abbott Laboratories Recent Developments
  19. 6.4 OraSure TechnologieS
  20. 6.4.1 OraSure TechnologieS Company Information
  21. 6.4.2 OraSure TechnologieS Business Overview
  22. 6.4.3 OraSure TechnologieS HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 OraSure TechnologieS HIV and AIDS Diagnostics Product Portfolio
  24. 6.4.5 OraSure TechnologieS Recent Developments
  25. 6.5 F. Hoffmann-La Roche
  26. 6.5.1 F. Hoffmann-La Roche Company Information
  27. 6.5.2 F. Hoffmann-La Roche Business Overview
  28. 6.5.3 F. Hoffmann-La Roche HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche HIV and AIDS Diagnostics Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche Recent Developments
  31. 6.6 Hologic
  32. 6.6.1 Hologic Company Information
  33. 6.6.2 Hologic Business Overview
  34. 6.6.3 Hologic HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Hologic HIV and AIDS Diagnostics Product Portfolio
  36. 6.6.5 Hologic Recent Developments
  37. 6.7 Abbott
  38. 6.7.1 Abbott Company Information
  39. 6.7.2 Abbott Business Overview
  40. 6.7.3 Abbott HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Abbott HIV and AIDS Diagnostics Product Portfolio
  42. 6.7.5 Abbott Recent Developments
  43. 6.8 Chembio Diagnostic Systems
  44. 6.8.1 Chembio Diagnostic Systems Company Information
  45. 6.8.2 Chembio Diagnostic Systems Business Overview
  46. 6.8.3 Chembio Diagnostic Systems HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Chembio Diagnostic Systems HIV and AIDS Diagnostics Product Portfolio
  48. 6.8.5 Chembio Diagnostic Systems Recent Developments
  49. 6.9 BD
  50. 6.9.1 BD Company Information
  51. 6.9.2 BD Business Overview
  52. 6.9.3 BD HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 BD HIV and AIDS Diagnostics Product Portfolio
  54. 6.9.5 BD Recent Developments
  55. 6.10 Danaher Corporation
  56. 6.10.1 Danaher Corporation Company Information
  57. 6.10.2 Danaher Corporation Business Overview
  58. 6.10.3 Danaher Corporation HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Danaher Corporation HIV and AIDS Diagnostics Product Portfolio
  60. 6.10.5 Danaher Corporation Recent Developments
7 North America
  1. 7.1 North America HIV and AIDS Diagnostics Market Size (2021-2032)
  2. 7.2 North America HIV and AIDS Diagnostics Market Size by Type
  3. 7.2.1 North America HIV and AIDS Diagnostics Market Size by Type (2021-2026)
  4. 7.2.2 North America HIV and AIDS Diagnostics Market Size by Type (2027-2032)
  5. 7.2.3 North America HIV and AIDS Diagnostics Market Share by Type (2021-2032)
  6. 7.3 North America HIV and AIDS Diagnostics Market Size by Application
  7. 7.3.1 North America HIV and AIDS Diagnostics Market Size by Application (2021-2026)
  8. 7.3.2 North America HIV and AIDS Diagnostics Market Size by Application (2027-2032)
  9. 7.3.3 North America HIV and AIDS Diagnostics Market Share by Application (2021-2032)
  10. 7.4 North America HIV and AIDS Diagnostics Market Size by Country
  11. 7.4.1 North America HIV and AIDS Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America HIV and AIDS Diagnostics Market Size by Country (2021-2026)
  13. 7.4.3 North America HIV and AIDS Diagnostics Market Size by Country (2027-2032)
  14. 7.4.4 North America HIV and AIDS Diagnostics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe HIV and AIDS Diagnostics Market Size (2021-2032)
  2. 8.2 Europe HIV and AIDS Diagnostics Market Size by Type
  3. 8.2.1 Europe HIV and AIDS Diagnostics Market Size by Type (2021-2026)
  4. 8.2.2 Europe HIV and AIDS Diagnostics Market Size by Type (2027-2032)
  5. 8.2.3 Europe HIV and AIDS Diagnostics Market Share by Type (2021-2032)
  6. 8.3 Europe HIV and AIDS Diagnostics Market Size by Application
  7. 8.3.1 Europe HIV and AIDS Diagnostics Market Size by Application (2021-2026)
  8. 8.3.2 Europe HIV and AIDS Diagnostics Market Size by Application (2027-2032)
  9. 8.3.3 Europe HIV and AIDS Diagnostics Market Share by Application (2021-2032)
  10. 8.4 Europe HIV and AIDS Diagnostics Market Size by Country
  11. 8.4.1 Europe HIV and AIDS Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe HIV and AIDS Diagnostics Market Size by Country (2021-2026)
  13. 8.4.3 Europe HIV and AIDS Diagnostics Market Size by Country (2027-2032)
  14. 8.4.4 Europe HIV and AIDS Diagnostics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China HIV and AIDS Diagnostics Market Size (2021-2032)
  2. 9.2 China HIV and AIDS Diagnostics Market Size by Type
  3. 9.2.1 China HIV and AIDS Diagnostics Market Size by Type (2021-2026)
  4. 9.2.2 China HIV and AIDS Diagnostics Market Size by Type (2027-2032)
  5. 9.2.3 China HIV and AIDS Diagnostics Market Share by Type (2021-2032)
  6. 9.3 China HIV and AIDS Diagnostics Market Size by Application
  7. 9.3.1 China HIV and AIDS Diagnostics Market Size by Application (2021-2026)
  8. 9.3.2 China HIV and AIDS Diagnostics Market Size by Application (2027-2032)
  9. 9.3.3 China HIV and AIDS Diagnostics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia HIV and AIDS Diagnostics Market Size (2021-2032)
  2. 10.2 Asia HIV and AIDS Diagnostics Market Size by Type
  3. 10.2.1 Asia HIV and AIDS Diagnostics Market Size by Type (2021-2026)
  4. 10.2.2 Asia HIV and AIDS Diagnostics Market Size by Type (2027-2032)
  5. 10.2.3 Asia HIV and AIDS Diagnostics Market Share by Type (2021-2032)
  6. 10.3 Asia HIV and AIDS Diagnostics Market Size by Application
  7. 10.3.1 Asia HIV and AIDS Diagnostics Market Size by Application (2021-2026)
  8. 10.3.2 Asia HIV and AIDS Diagnostics Market Size by Application (2027-2032)
  9. 10.3.3 Asia HIV and AIDS Diagnostics Market Share by Application (2021-2032)
  10. 10.4 Asia HIV and AIDS Diagnostics Market Size by Country
  11. 10.4.1 Asia HIV and AIDS Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia HIV and AIDS Diagnostics Market Size by Country (2021-2026)
  13. 10.4.3 Asia HIV and AIDS Diagnostics Market Size by Country (2027-2032)
  14. 10.4.4 Asia HIV and AIDS Diagnostics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa HIV and AIDS Diagnostics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa HIV and AIDS Diagnostics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa HIV and AIDS Diagnostics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa HIV and AIDS Diagnostics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa HIV and AIDS Diagnostics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst